NSE filing, NSE: ACCPL. Summary written from the filing by ALFA Finder's alert engine.
Accretion Pharmaceuticals Ltd: key numbers
- Share price
- ₹203.00
- Market cap
- ₹225.7 Cr
- Revenue (annual)
- ₹89.63 Cr
- Net profit (annual)
- ₹9.67 Cr
- P/E (TTM)
- 23.3×Sector 37.9×
- Promoter holding
- 73.52%+0.00% QoQ
- FII holding
- 0.17%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Accretion Pharmaceuticals Ltd
All →Accretion Pharmaceuticals Investor Presentation: Key Takeaways
H1 FY27 revenue ₹55.04 Cr (+25.83% YoY), PAT ₹8.20 Cr (+72.63%), EBITDA margin 22.48%. Export share rose to 18.15%.
Accretion Pharmaceuticals Results Update
Accretion Pharmaceuticals reported H1 FY27 net revenue up 25.83% to ₹55.04 crore and PAT up 72.63% to ₹8.20 crore via media release. EBITDA margin improved to 22.48%.
Accretion Pharmaceuticals H1 FY27 Results: Net Profit ₹8.2 Cr, Up 70.8% YoY
Accretion Pharmaceuticals reported unaudited standalone half-year results to 30 September 2026, with revenue of Rs 5,504.10 lakh and profit after tax of Rs 820.14 lakh. The results carry a limited review report from VSSB & Associates.
- Key figure
- Net profit ₹8.2 Cr · +70.8% YoY
Accretion Pharmaceuticals Annual General Meeting
Accretion Pharmaceuticals Limited announced the results of its postal ballot, where shareholders approved five special resolutions, including increasing borrowing limits and charging company assets.
Accretion Pharmaceuticals Other Announcement
Accretion Pharmaceuticals Limited submitted the confirmation certificate under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended September 30, 2026.
Accretion Pharmaceuticals Annual General Meeting
Accretion Pharmaceuticals Limited issued a postal ballot notice to shareholders to seek approval for altering the company's Memorandum of Association (Object Clause).
Other board meeting date announcements
All →Hindware Home Innovation Board Meeting Date
Hindware Home Innovation's board will meet on 13 November 2026 to approve unaudited Q2 and half-year results. The meeting notice also proposes routine matters beyond the results.
Dish TV India Board Meeting Date
Dish TV India's board will meet on 12 November 2026 to consider unaudited Q2 and half-year results. The trading window remains closed until 14 November 2026.
Keynote Financial Services Board Meeting Date
Keynote Financial Services scheduled a board meeting for November 13, 2026, to approve unaudited half-year results. The trading window stays closed until 48 hours after results disclosure.
Bazel International Board Meeting Date
Bazel International scheduled a board meeting for 12 November 2026 to consider quarterly and half-year results. The trading window remains closed until results are declared.
Chandni Machines Board Meeting Date
Chandni Machines will hold a board meeting on 13 November 2026 for quarterly unaudited standalone results. The trading window remains closed until results are declared.
Compucom Software Board Meeting Date
Compucom Software has scheduled a board meeting on November 13, 2026 to approve unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. The filing also restates the trading window closure for designated persons.